世界の関節痛注射市場

出版:Inkwood Research(インクウッドリサーチ) 出版年月:2021年11月

GLOBAL JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
世界の関節痛注射市場予測 2022-2030

ページ数 206
価格
シングルユーザライセンス USD 2,500
マルチユーザライセンス USD 3,000
エンタープライズライセンス USD 4,500
種別 英文調査報告書

このレポートへお問合せ  レポート目次

関連市場調査レポート

Inkwood Researchでは下記地域/国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。

    • アジア太平洋の関節痛注射市場予測 2022-2030
      ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
    • ヨーロッパの関節痛注射市場予測 2022-2030
      EUROPE JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
    • 北米の関節痛注射市場予測 2022-2030
      NORTH AMERICA JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
    • 日本の関節痛注射市場予測 2022-2028
      JAPAN JOINT PAIN INJECTIONS MARKET FORECAST 2022-2028

KEY FINDINGS
The global joint pain injections market is anticipated to register a CAGR of 8.56% during the forecast years of 2022 to 2030. The market growth is attributable to key drivers such as the increased prevalence of bone and joint-related diseases across the geriatric population, the increasing number of sports injuries, and the rising incidence of musculoskeletal disorders.
MARKET INSIGHTS
Joint pain injections are medicinal fluids introduced into the patient’s body in order to facilitate faster relief from severe pain. They are utilized to reduce inflammation in the joints. Several types of injections available in the market include corticosteroids injections, platelet-rich plasma (PRP) injections, hyaluronic acid (HA) injections, as well as placental tissue matrix (PTM) injections.
Musculoskeletal disorders (MSDs) entail medical conditions impacting muscles, bones, and joints of the shoulders, neck, wrists, hips, legs, back, knees, and feet. These diseases include tendinitis, osteoarthritis, carpal tunnel syndrome, rheumatoid arthritis (RA), bone fractures, and fibromyalgia. According to the World Health Organization (WHO) factsheet updated in 2021, around 1.71 billion people have musculoskeletal conditions globally. Moreover, among musculoskeletal disorders, low back pain represents the highest burden, prevalent in approximately 568 million people. The high incidence of musculoskeletal disorders in different countries increases the number of treatment procedures conducted for the same, thus fueling the global joint pain injections market growth.
REGIONAL INSIGHTS
The global joint pain injections market growth evaluation comprises the assessment of Asia-Pacific, North America, Europe, and Rest of World. North America held the highest revenue share in 2021. The region’s market growth is primarily facilitated by the augmenting demand for advanced therapeutic platforms to enhance treatment outcomes and the rising number of new product launches and approvals.
COMPETITIVE INSIGHTS
The competition among tier 1 companies as well as tier 2 and tier 3 companies in the global joint pain injections market is increasing. Moreover, the threat of rivalry is high among market players within their respective segments. Vendors also differentiate their products on the basis of quality, cost, and application.
Some of the top firms operating in the market are Allergan PLC, Sanofi, Pfizer Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS: ORTHOPEDIC PROCEDURES MARKET
3.2. KEY DRIVERS
3.2.1. BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
3.2.2. GROWING NUMBER OF SPORT INJURIES
3.2.3. PREVALENCE OF MUSCULOSKELETAL DISORDERS
3.3. KEY RESTRAINTS
3.3.1. HIGH COSTS OF JOINT REPAIR THERAPIES
3.3.2. SIDE EFFECTS ASSOCIATED WITH JOINT REPAIR INJECTIONS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON JOINT PAIN INJECTIONS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. NEW ENTRY
4.3.4. SUBSTITUTION
4.3.5. INDUSTRY RIVALRY
4.4. KEY BUYING CRITERIA
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE
5. MARKET BY JOINT TYPE
5.1. KNEE
5.2. SHOULDER AND ELBOW
5.3. HIP
5.4. FOOT AND ANKLE
5.5. OTHER JOINT TYPES
6. MARKET BY INJECTION TYPE
6.1. HYALURONIC ACID
6.2. CORTICOSTEROID
6.3. OTHER DRUGS
7. MARKET BY DISTRIBUTION CHANNEL
7.1. HOSPITALS PHARMACIES
7.2. RETAIL PHARMACIES
7.3. OTHER DISTRIBUTION CHANNELS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. KEY GROWTH ENABLERS
8.2.3. KEY CHALLENGES
8.2.4. KEY PLAYERS
8.2.5. COUNTRY ANALYSIS
8.2.5.1. GERMANY
8.2.5.2. FRANCE
8.2.5.3. UNITED KINGDOM
8.2.5.4. ITALY
8.2.5.5. SPAIN
8.2.5.6. NORDIC COUNTRIES
8.2.5.7. RUSSIA
8.2.5.8. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. KEY GROWTH ENABLERS
8.3.3. KEY CHALLENGES
8.3.4. KEY PLAYERS
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.2. JAPAN
8.3.5.3. INDIA
8.3.5.4. AUSTRALIA & NEW ZEALAND
8.3.5.5. SOUTH KOREA
8.3.5.6. INDONESIA
8.3.5.7. TAIWAN
8.3.5.8. SINGAPORE
8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. KEY GROWTH ENABLERS
8.4.3. KEY CHALLENGES
8.4.4. KEY PLAYERS
8.4.5. REGIONAL ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ALLERGAN PLC (ACQUIRED BY ABBVIE)
9.2.2. ANIKA THERAPEUTICS INC
9.2.3. BIOVENTUS INC
9.2.4. CHUGAI PHARMACEUTICAL
9.2.5. FERRING PHARMACEUTICALS
9.2.6. FIDIA PHARMA USA INC
9.2.7. FLEXION THERAPEUTICS INC
9.2.8. ORTHOGENRX INC
9.2.9. PFIZER INC
9.2.10. SANOFI
9.2.11. SEIKAGAKU CORPORATION
9.2.12. SMITH & NEPHEW PLC
9.2.13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
9.2.14. ZIMMER BIOMET HOLDINGS

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – JOINT PAIN INJECTIONS
TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, BY GEOGRAPHIC REGION, 2019 AND 2050
TABLE 3: GLOBAL JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: GLOBAL JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: GLOBAL KNEE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL KNEE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL SHOULDER AND ELBOW MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL SHOULDER AND ELBOW MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL HIP MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL HIP MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL FOOT AND ANKLE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL FOOT AND ANKLE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL OTHER JOINT TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL OTHER JOINT TYPES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL HYALURONIC ACID MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL HYALURONIC ACID MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL CORTICOSTEROID MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL CORTICOSTEROID MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL OTHER DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL OTHER DRUGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL HOSPITALS PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL HOSPITALS PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: GLOBAL JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: GLOBAL JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN THE NORTH AMERICA JOINT PAIN INJECTIONS MARKET
TABLE 36: EUROPE JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 37: EUROPE JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 38: LEADING PLAYERS OPERATING IN EUROPE JOINT PAIN INJECTIONS MARKET
TABLE 39: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 40: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 41: LEADING PLAYERS OPERATING IN ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET
TABLE 42: REST OF WORLD JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 43: REST OF WORLD JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 44: LEADING PLAYERS OPERATING IN REST OF WORLD JOINT PAIN INJECTIONS MARKET
TABLE 45: LIST OF MERGERS & ACQUISITIONS
TABLE 46: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 47: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 48: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, IN 2021
FIGURE 6: GLOBAL JOINT PAIN INJECTIONS MARKET, BY KNEE, 2022-2030 (IN $ MILLION)
FIGURE 7: GLOBAL JOINT PAIN INJECTIONS MARKET, BY SHOULDER AND ELBOW, 2022-2030 (IN $ MILLION)
FIGURE 8: GLOBAL JOINT PAIN INJECTIONS MARKET, BY HIP, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL JOINT PAIN INJECTIONS MARKET, BY FOOT AND ANKLE, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL JOINT PAIN INJECTIONS MARKET, BY OTHER JOINT TYPES, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, IN 2021
FIGURE 12: GLOBAL JOINT PAIN INJECTIONS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL JOINT PAIN INJECTIONS MARKET, BY CORTICOSTEROID, 2022-2030 (IN $ MILLION)
FIGURE 14: GLOBAL JOINT PAIN INJECTIONS MARKET, BY OTHER DRUGS, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, IN 2021
FIGURE 16: GLOBAL JOINT PAIN INJECTIONS MARKET, BY HOSPITALS PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 17: GLOBAL JOINT PAIN INJECTIONS MARKET, BY RETAIL PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 18: GLOBAL JOINT PAIN INJECTIONS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 20: UNITED STATES JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: CANADA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 23: GERMANY JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: FRANCE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: UNITED KINGDOM JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: ITALY JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: SPAIN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: NORDIC COUNTRIES JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: RUSSIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: REST OF EUROPE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 32: CHINA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: JAPAN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: INDIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: SOUTH KOREA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: INDONESIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: TAIWAN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: SINGAPORE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: REST OF WORLD JOINT PAIN INJECTIONS MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 42: LATIN AMERICA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)


お問合せフォーム

    お問合せ/ご依頼内容

    • レポートのタイトルは自動で入ります。
    • ※のある項目は必須項目です。

    お名前(

    会社名(

    部署名

    メールアドレス(

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com